Coverage
-
July 05, 2018
A New Jersey federal judge Thursday dismissed Sunovion Pharmaceuticals Inc.'s patent infringement suit against MSN Laboratories and Sandoz Inc. over its bipolar medication Latuda after the parties reached a deal and MSN agreed to delay its generic version of the drug until Sunovion's patent expires.
1 other articles on this case.
View all »